Nichiban Co., Ltd. (TYO:4218)
1,961.00
-13.00 (-0.66%)
Jul 30, 2026, 3:30 PM JST
Nichiban Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 50,470 | 50,470 | 49,457 | 46,859 | 45,560 | 43,134 |
Revenue Growth | 2.05% | 2.05% | 5.54% | 2.85% | 5.62% | 3.87% |
Gross Profit Gross Profit Growth | 15,025 | 15,025 | 14,902 | 13,871 | 12,974 | 13,496 |
Operating Income Operating Income Growth | 2,271 | 2,271 | 2,587 | 2,073 | 1,609 | 2,450 |
Net Income Net Income Growth | 1,652 | 1,652 | 1,959 | 1,827 | 2,371 | 1,809 |
Earnings Per Share EPS Growth | 81.17 | 81.17 | 96.23 | 88.97 | 114.65 | 87.30 |
EPS Growth | -15.65% | -15.65% | 8.16% | -22.40% | 31.33% | 34.00% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Unallocated Adjustment Unallocated Adjustment Growth | -164 | -164 | -154 | -163 | -156 | -410 |
Medical Business Medical Business Growth | 25,030 | 25,030 | 24,673 | 22,785 | 21,076 | 19,214 |
Tape Business Tape Business Growth | 25,605 | 25,605 | 24,938 | 24,237 | 24,640 | 24,329 |
Total Total Growth | 50,471 | 50,471 | 49,457 | 46,859 | 45,560 | 43,133 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 14,128 | 14,128 | 14,663 | 13,405 | 15,108 | 14,200 |
Total Debt Total Debt Growth | 2,733 | 2,733 | 2,431 | 2,762 | 4,113 | 3,009 |
Net Cash (Debt) Net Cash Growth | 11,395 | 11,395 | 12,232 | 10,643 | 10,995 | 11,191 |
Net Cash Growth | -6.84% | -6.84% | 14.93% | -3.20% | -1.75% | 2.35% |
Net Cash Per Share Net Cash Per Share Growth | 559.77 | 559.77 | 600.73 | 518.22 | 531.63 | 540.08 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,540 | 2,540 | 3,690 | 3,187 | 2,917 | 4,064 |
Capital Expenditures CapEx Growth | -1,904 | -1,904 | -1,295 | -3,546 | -2,550 | -2,411 |
Free Cash Flow Free Cash Flow Growth | 636 | 636 | 2,395 | -359 | 367 | 1,653 |
Free Cash Flow Growth | -73.45% | -73.45% | - | - | -77.80% | -58.83% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 29.77% | 29.77% | 30.13% | 29.60% | 28.48% | 31.29% |
Operating Margin | 4.50% | 4.50% | 5.23% | 4.42% | 3.53% | 5.68% |
Pretax Margin | 4.21% | 4.21% | 5.31% | 4.85% | 7.53% | 5.93% |
Profit Margin | 3.27% | 3.27% | 3.96% | 3.90% | 5.20% | 4.19% |
FCF Margin | 1.26% | 1.26% | 4.84% | -0.77% | 0.81% | 3.83% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 40.000 | 40.000 | 35.000 | 35.000 | 35.000 | 30.000 |
Dividend Per Share Growth | 14.29% | 14.29% | 0% | 0% | 16.67% | 0% |
Dividend Yield | 2.03% | 2.13% | 1.78% | 1.83% | 1.92% | 1.90% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 24.16 | 22.92 | 20.87 | 22.10 | 16.72 | 19.47 |
Forward PE | 23.99 | 22.47 | 17.08 | 19.74 | 18.58 | 17.89 |
P/FCF Ratio | 62.22 | 59.53 | 17.07 | - | 108.00 | 21.31 |
PS Ratio | 0.78 | 0.75 | 0.83 | 0.86 | 0.87 | 0.82 |